CONFERENCE ORGANIZERS
Dr. Peter Jones, University of Manitoba, Canada
Dr. Jerzy Zawistowski, University of British Columbia, Canada
Dr. Sefa Koseoglu, Bioactives World Forum, USA
Ms. Kelly Fitzpatrick, Nutritech Consulting, Canada
Dr. David Kitts, University of British Colombia, Canada
|
|
DECEMBER 10, 2009
|
|
Plenary Session: |
8:50 am |
Welcome, Peter Jones, Richardson Centre for Functional
Foods and Nutraceuticals, Winnipeg, Canada
|
9:00 am |
Omega 3 Market Overview: Products, Size and
Applications, Adam Ismail, GOED, Salt Lake City, UT,
USA |
|
Session 1. Bioactive Ingredients for Heart Health and
Scientific Substantiation |
10:00 am |
Soluble Fiber and Health, Gary Fulcher, Food Science
Department, University of Manitoba, Winnipeg, MB, Canada |
10:30 am |
Coffee/Tea Break |
11:00 am |
Phytosterols in Disease Reduction and Health,
Peter Jones, Food Science Department, University of Manitoba,
Winnipeg, MB, Canada |
11:30 am |
Heart Health Benefits of Antioxidant Functional
Foods – True or False, David Kitts. Food, Nutrition and
Health, University of British Columbia, Vancouver, BC, Canada |
12:00 n |
Antihypertensive Properties of Milk Polypeptides
and Their Commercial Applications, Pauliina Jakala,
Institute of Biomedicine, Pharmacology, University of Helsinki,
and Anu Turpeinen, Valio Ltd., Finland |
12:30 pm |
Networking Luncheon |
|
Session 2. Global Regulations for Heart Health Functional
Foods- Approval Venues and Health Claims |
2:00 pm |
US Regulations – Health Claims and Labeling,
Clare Hasler, Robert Mondavi Institute for Wine and Food
Science, University of California, Davis, CA, USA |
2:30 pm |
NHPD – A Potential Venue for Regulatory
Approval of Functional Foods in Canada, Kelley
Fitzpatrick, President, Nutritech Consulting, Winnipeg, MB |
3:00 pm |
Functional Foods and Health Claims: EU and
Other Countries Perspective, Jerzy Zawistowski, Food, Nutrition and Health, University
of British Columbia, Vancouver, BC, Canada |
3:30 pm |
Coffee / Tea Break |
|
Session 3. Clinical Trials and Safety |
4:00 pm |
Importance of Clinical Studies in Support of
Commercialization of Heart Health Products - How Far We Should Go? Michael Lyon, Canadian
Center for Functional Medicine, Coquitlam, BC, Canada |
4:30 pm |
New Techniques and Developments for
Monitoring Safety, Ashley Roberts, Cantox, Missisauga,
ON, Canada |
5:00 pm |
Interruption of Enterohepatic Circulation of Organochlorines to Reduce Risk of Diabetes and Cardiovascular Disease, Ron
Jandacek, Proctor and Gamble, Cincinnati, OH, USA |
|
DECEMBER 11, 2009 |
|
Session 4. Challenges in Heart Health Food Formulations
and Commercialization |
8:30 am |
Multi Plex Matrix: A New «Whey» to Capture
Obesity-Related Metabolic Disorders, Pierre
Lamieux, BiolActis Inc., Laval, P.Q., Canada |
9:00 am |
Product Formulation Issues - How to
Incorporate Water-insoluble Sterols into
Aqueous-base Food Products, Mira Laza, Omnia
Foods Ltd., Vancouver, BC, Canada |
9:30 am |
To Patent or not to Patent and When? Is Trade
Secret a Solution? - Dilemma Facing Small and
Medium Size Producers, Susan Ben-Oliel, Patent &
Trade-mark Agency, Vancouver, BC, Canada |
10:00 am |
Coffee/Tea Break |
|
Session 5. Emerging Trends in the Area of Heart Health |
10:30 am |
Global Trends in Functional Foods and Heart
Health Products, Svetlana Uduslivaia, Euromonitor International, Chicago, IL, USA |
11:00 am |
Future Approaches in Heart Disease Risk
Reduction, Yanwen Wang, Institute for Nutrisciences and
Health, NRC, Charlottetown, PEI, Canada |
11:30 am |
Nutragenomics: Tailoring Food to Improve Heart
Health Status, Keith Randolph, Technology Strategist,
Access Business Group LLC, Buena Park, CA, USA |
12:00 n - 1:00 pm |
Tour of the Richardson Centre for Functional
Foods and Nutraceuticals Facilities |
| |
|
|
